Assessing pharmacists’ readiness to prescribe oral antibiotics for limited infections using a case-vignette technique

International Journal of Clinical Pharmacy

Volumn 39, Issue 1, 2017, Pages 61-69

  Ung, Elizabeth ^a   Czarniak, Petra ^a   Sunderland, Bruce ^a   Parsons, Richard ^a   Hoti, Kreshnik ^a,b  

^a CURTIN UNIVERSITY   (Australia)

^b UNIVERSITY OF PRISHTINA   (Serbia)

Author keywords

Australia; Case vignettes; Community pharmacies; Limited infections; Oral antibiotics; Pharmacist prescribing; Pharmacists

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFACLOR; CEFALEXIN; CEFUROXIME; CLARITHROMYCIN; CLINDAMYCIN; DOXYCYCLINE; ERYTHROMYCIN; FLUCLOXACILLIN; METRONIDAZOLE; MINOCYCLINE; NORFLOXACIN; PENICILLIN DERIVATIVE; ROXITHROMYCIN; TINIDAZOLE; TRIMETHOPRIM; VANCOMYCIN; ANTIINFECTIVE AGENT;

ACNE; ADULT; ARTICLE; BACTERIAL SINUSITIS; BACTERIAL SKIN DISEASE; CELLULITIS; CONTROLLED STUDY; DISEASE SEVERITY; DRUG INDICATION; FEMALE; HUMAN; INAPPROPRIATE PRESCRIBING; INFECTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PENICILLIN ALLERGY; PHARMACIST ATTITUDE; PHARMACY; PRESCRIPTION; PROFESSIONAL COMPETENCE; QUESTIONNAIRE; RASH; RECURRENT INFECTION; RURAL POPULATION; URINARY TRACT INFECTION; VIGNETTE; WESTERN AUSTRALIA; YOUNG ADULT; ORAL DRUG ADMINISTRATION; PHARMACIST; PROFESSIONAL STANDARD; PSYCHOLOGY; URINARY TRACT INFECTIONS;

ADMINISTRATION, ORAL; ADULT; ANTI-BACTERIAL AGENTS; CELLULITIS; COMMUNITY PHARMACY SERVICES; DRUG PRESCRIPTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; PHARMACISTS; PROFESSIONAL ROLE; SURVEYS AND QUESTIONNAIRES; URINARY TRACT INFECTIONS; YOUNG ADULT;

EID: 84995387864     PISSN: 22107703     EISSN: 22107711     Source Type: Journal    
DOI: 10.1007/s11096-016-0396-0     Document Type: Article

References (38)

1. Emmerton L, Marriott J, Bessell T, Nissen L, Dean L. Pharmacists and prescribing rights: review of international developments. J Pharm Pharm Sci. 2005;8(2):217–25.
2. Barry A. Media release—milestone for pharmacists. Pharmacy Council of New Zealand; 2013. http://www.pharmacycouncil.org.nz/cms_show_download.php?id=392. Accessed 25 Sep 2016.
3. Courtenay M, Carey N, Stenner K. An overview of non medical prescribing across one strategic health authority: a questionnaire survey. BMC Health Serv Res. 2012;12:138.
4. Baqir W, Miller D, Richardson G. A brief history of pharmacist prescribing in the UK. Eur J Hosp Pharm. 2012;19(5):487–8.
5. Commonwealth of Australia. Prescribing medicines—information for PBS prescribers. Canberra: Department of Health; 2014. http://www.pbs.gov.au/info/healthpro/explanatory-notes/section1/Section_1_2_Explanatory_Notes#PBS-prescribers. Accessed 25 Sep 2016.
6. Nissen L, Kyle G. Non-medical prescribing in Australia. Aust Prescr. 2010;33(6):166–7.
7. Haggan M. Community pharmacy to fight for expanded role. AJP; 2015. http://ajp.com.au/news/community-pharmacy-fight-expanded-role-quilty/. Accessed 25 Sep 2016.
8. The Pharmaceutical Society of Australia. Guidelines for the continued dispensing of eligible prescribed medicines by pharmacist. Canberra: Pharmaceutical Society of Australia; 2012. http://www.psa.org.au/downloads/ent/uploads/filebase/guidelines/medication-management/continued-dispensing-practice-guide.pdf. Accessed 11 Oct 2016.
9. The Pharmaceutical Society of Australia. Guidance for provision of a pharmacist only medicine: Famciclovir. Canberra: Pharmaceutical Society of Australia; 2014. http://www.psa.org.au/downloads/ent/uploads/filebase/guidelines/s3/famciclovir-protocol.pdf. Accessed 11 Oct 2016.
10. The Pharmaceutical Society of Australia. Guidance for provision of a pharmacist only medicine: Fluconazole. Canberra: Pharmaceutical Society of Australia; 2014. http://www.psa.org.au/downloads/ent/uploads/filebase/guidelines/s3/Fluconazole-protocol.pdf. Accessed 11 Oct 2016.
11. The Pharmaceutical Society of Australia. Provision of chloramphenicol for ophthalmic use as a pharmacist only medicine. Canberra: Pharmaceutical Society of Australia; 2014. http://www.psa.org.au/download/ent/uploads/filebase/guidelines/s3/Chloramphenicol-protocol.pdf. Accessed 11 Oct 2016.
12. The Pharmaceutical Society of Australia. Immunisation roundup: state and territories; 2015. http://www.psa.org.au/qualifications/pharmacist-training/immunisation-roundup-states-and-territories. Accessed 25 Sep 2016.
13. Fifth Community Pharmacy Agreement & The Pharmacy Guild of Australia. Medication management initiatives; 2014. http://5cpa.com.au/programs/medication-management-initiatives/medscheck-diabetes-medscheck/. Accessed 25 Sep 2016.
14. Daniels A. Forging team health-creating a new game. Aust Pharm. 2015;34(8):30.
15. Health Workforce Australia. Health professionals prescribing pathway (HPPP) project-final report; 2013. http://www.healthinfonet.ecu.edu.au/key-resources/bibliography/?lid=26503. Accessed 11 Oct 2016.
16. The Pharmacy Guild of Australia. Community pharmacy roadmap program development template Australia. The pharmacy guild of Australia; 2014. http://www.guild.org.au/docs/default-source/public-documents/tab—the-guild/Strategic-Direction/pharmacist-prescribing.pdf. Accessed 25 Sep 2016.
17. Keast K. Australia’s first allied health prescribing training. Health times; 2014. http://healthtimes.com.au/hub/pain-management/44/guidance/kk1/australias-first-allied-health-prescribing-training/67/. Accessed 25 Sep 2016.
18. Hoti K, Hughes J, Sunderland B. Identifying the perceived training needs for Australian pharmacist prescribers. Int J Pharm Pract. 2014;22(1):38–46.
19. Department of Health. Improving patients’ access to medicines: a guide to implementing nurse and pharmacist independent prescribing within the NHS in England 2006. London: Department of Health; 2006. http://webarchive.nationalarchives.gov.uk/20130107105354/http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_4133747.pdf. Accessed 25 Sep 2016.
20. Department of Health. Nurse and pharmacist independent prescribing changes annouced; 2012. https://www.gov.uk/government/news/nurse-and-pharmacist-independent-prescribing-changes-announced. Accessed 11 Jun 2016.
21. Zayegh I, Charrois TL, Hughes J, Hoti K. Antibiotic repeat prescriptions: are patients not-refilling them properly? J Pharm Policy Pract. 2014;7(1):17.
22. Duckett S, Breadon P, Ginnivan L. Access all areas: new solutions for GP shortages in rural Australia. Melbourne: Grattan Institute; 2013.
23. Bessell T, Marriot J, Emmerton L, Nissen L. Improving Australians’ access to prescription medicines: development of pharmacy practice models (final report). Australia: Pharmacy Guild of Australia; 2005. http://www.guild.org.au/services-programs/research-and-development/archive—third-agreement/2003-017. Accessed 25 Sep 2016.
24. Silmalis L. Pharmacists given green light to give flu jabs on the spot instead of doctors or nurses. The Daily Telegraph; 2015. http://www.dailytelegraph.com.au/news/nsw/pharmacists-given-green-light-to-give-flu-jabs-on-the-spot-instead-of-doctors-or-nurses/story-fni0cx12-1227300138286. Accessed 25 Sept 2016.
25. Charrois T, Rosenthal M, Hoti K, Hughes C. Pharmacy student perceptions of pharmacist prescribing: a comparison study. Pharmacy. 2013;1(2):237–347.
26. Hoti K, Hughes J, Sunderland B. Expanded prescribing: a comparison of the views of Australian hospital and community pharmacists. Int J Clin Pharm. 2013;35(3):469–75.
27. Hoti K, Hughes K, Sunderland B. Pharmacy client’s attitudes to expanded pharmacist prescribing and the role of agency theory on involved stakeholders. Int J Pharm Pract. 2011;19(1):5–12.
28. Hoti K, Sunderland B, Hughes J, Parsons R. An evaluation of Australian pharmacist’s attitudes on expanding their prescribing role. Pharm World Sci. 2010;32(5):610–21.
29. Vracar D, Bajorek BV. Australian general practitioners’ views on pharmacist prescribing. J Pharm Pract Res. 2008;38(2):96–102.
30. Kay OC, Bajorek VB, Brien JE. Pharmacist prescribing activities—an electronic survey on the opinions of Australian pharmacists. J Pharm Pract Res. 2006;36(3):199–203.
31. Hoti K, Hughes J, Sunderland B. An expanded prescribing role for pharmacists—an Australian perspective. Aust Med J. 2011;4(4):236–42.
32. Res R, Hoti K, Charrois TL. Pharmacists’ perceptions regarding optimization of antibiotic prescribing in the community. J Pharm Pract. 2016; pii:0897190015623883 [Epup ahead of print].
33. Alkhatib L, Parsons R, Czarniak P, Sunderland VB. An evaluation of the reclassification of ophthalmic chloramphenicol for the management of acute bacterial conjunctivitis in community pharmacies in Western Australia. Int J Pharm Pract. 2015;23(2):111–20.
34. Boynton P, Greenhalgh T. Hands-on guide to questionnaire research—selecting, designing, and developing your questionnaire. BMJ. 2004;328(7451):1312–5.
35. Taylor BJ. Factorial surveys: using vignettes to study professional judgement. Br J Soc Work. 2006;36:1187–207.
36. Spalding NJ, Phillips T. Exploring the use of vignettes: from validity to trustworthiness. Qual Health Res. 2007;17(7):954–62.
37. Antibiotic Expert Groups. Therapeutic guidelines: antibiotic. Version 15. Melbourne: Therapeutic Guidelines; 2014.
38. Pharmacy Registration Board of Western Australia. Premise register; 2015. http://www.pharmacyboardwa.com.au/?n=Main.Register. Accessed 25 Sep 2016.